|
|
|
Insider
Information: |
Cooper Laurence James Neil |
Relationship: |
President and CEO, Dir... |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
1,799,280 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$303,359 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,799,280 |
|
|
Total
Value |
$303,359 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alaunos Therapeutics |
TCRT |
President and CEO, Dir... |
2021-01-04 |
1,799,280 |
2015-05-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2015-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000,000 |
1,000,000 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
131,000 |
1,131,000 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2016-05-05 |
4 |
D |
$6.86 |
$800,336 |
D/D |
(116,667) |
1,014,333 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2016-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
212,250 |
1,226,583 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2016-12-31 |
4 |
D |
$5.35 |
$92,512 |
D/D |
(17,292) |
1,209,291 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2017-05-05 |
4 |
D |
$7.12 |
$939,840 |
D/D |
(132,000) |
1,077,291 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2017-11-08 |
4 |
B |
$4.68 |
$30,139 |
D/D |
6,440 |
1,083,731 |
2.74 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2017-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
348,000 |
1,431,731 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2017-12-30 |
4 |
D |
$4.14 |
$108,377 |
D/D |
(26,178) |
1,405,553 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2017-12-31 |
4 |
D |
$4.14 |
$66,890 |
D/D |
(16,157) |
1,389,396 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2018-05-05 |
4 |
D |
$4.41 |
$543,899 |
D/D |
(123,333) |
1,266,063 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2018-12-29 |
4 |
D |
$1.66 |
$71,247 |
D/D |
(42,920) |
1,223,143 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2018-12-30 |
4 |
D |
$1.66 |
$43,455 |
D/D |
(26,178) |
1,196,965 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2018-12-31 |
4 |
D |
$1.87 |
$30,212 |
D/D |
(16,156) |
1,180,809 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2019-01-06 |
4 |
D |
$2.24 |
$369,999 |
D/D |
(165,178) |
1,799,325 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2019-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
783,694 |
1,964,503 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2019-12-27 |
4 |
OE |
$2.24 |
$99,998 |
D/D |
44,642 |
1,843,967 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2019-12-30 |
4 |
AS |
$4.88 |
$540,187 |
D/D |
(110,694) |
1,733,273 |
0 |
% |
|
TCRT |
Alaunos Therapeutics |
Chief Executive Officer |
|
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
171,700 |
1,904,973 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
President and CEO |
|
2021-01-04 |
4 |
AS |
$2.71 |
$286,428 |
D/D |
(105,693) |
1,799,280 |
0 |
% |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|